Top

Intensive Care Medicine

Published in:

01-11-2006 | Review

Ethics and research in critical care

Authors: Henry J. Silverman, Francois Lemaire

Published in: Intensive Care Medicine | Issue 11/2006

Abstract

Background

The past few years have witnessed several controversies regarding the ethics of conducting research involving critically ill patients, and such research is ethically challenging.

Discussion

Research ethics is a changing field, one that is influenced by empirical data, contemporary events, and new ideas regarding aspects of clinical trial design and protection of human subjects. We describe recent thoughts regarding several aspects of research ethics in the critical care context.

Conclusion

The ability of the research community to conduct research ethically and to maintain public trust would benefit from heightened awareness to the principles and requirements that govern such research.

National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1979) The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. U.S. Government Printing Office, Washington

Emanuel EJ, Wendler D, Grady C (2000) What makes clinical research ethical? JAMA 283:2701–2711PubMedCrossRef

Anonymous (2001) Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off J Eur Communities L121:33–44

London AJ, Kadane JB (2002) Placebos that harm: sham surgery controls in clinical trials. Stat Methods Med Res 11:413–427PubMedCrossRef

Freedman B (1987) Equipoise and the ethics of clinical research. N Engl J Med 317:141–145PubMedCrossRef

Dreyfuss D (2005) Is it better to consent to an RCT or to care? Intensive Care Med 31:345–355PubMedCrossRef

Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892PubMedCrossRef

Mann H, Djulbegovic B (2003) Choosing a control intervention for a randomised clinical trial. BMC Med Res Methodol 3:7PubMedCrossRef

Silverman HJ, Miller FG (2004) Control group selection in critical care randomized controlled trials evaluating interventional strategies: An ethical assessment. Crit Care Med 32:852–857PubMedCrossRef

10.

Miller FG, Silverman HJ (2004) The ethical relevance of the standard of care in the design of clinical trials. Am J Respir Crit Care Med 169:562–564PubMedCrossRef

11.

Parshuram CS, Kavanagh BP (2004) Positive clinical trials. Understand the control group before implementing the result. Am J Respir Crit Care Med 170:223–226PubMedCrossRef

12.

Gutierrez G, Palizas F, Doglio G, Wainsztein N, Gallesio A, Pacin J, Dubin A, Schiavi E, Jorge M, Pusajo J ea (1992) Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet 339:195–199PubMedCrossRef

13.

Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, Laporta DP, Viner S, Passerini L, Devitt H, Kirby A, Jacka M, Canadian Critical Care Clinical Trials Group (2003) A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 348:5–14PubMedCrossRef

14.

Richard C, Warszawski J, Anguel N, Deye N, Combes A, Barnoud D, Boulain T, Lefort Y, Fartoukh M, Baud F, Boyer A, Brocahrd L, Teboul JL, for the French Pulmonary Artery Catheter Study Group (2003) Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome. A randomized controlled trial. JAMA 290:2713–2720PubMedCrossRef

15.

Harvey S, Harrison DA, Singer M, Ashcroft J, Jones CM, Elbourme D, Brampton W, Williams D, Young DR, Rowan K, PAC-Man Study collaboration (2005) Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomized controlled trial. Lancet 366:472–477PubMedCrossRef

16.

SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256CrossRef

17.

Krishnan JA, Moore D, Roveson C, Rand CS, Fessler HE (2004) A prospective, controlled trial of a protocol-based strategy to discontinue mechanical ventilation. Am J Respir Crit Care Med 169:673–678PubMedCrossRef

18.

Randolph AG, Wjypij D, Venkataraman ST, Hanson JH, Gedeit rG, Meert KL, Luckett PM, Forbes P, Lilley M, Thompson J (2002) Effect of mechanical ventilator weaning protocols on respiratory outcomes in infants and children: a randomized controlled trial. JAMA 288:2561–2568PubMedCrossRef

19.

Ely EW, Baker AM, Duagan DP, Burke HL, Smith AC, Kelly PT, Johnson MM, Browder RW, Bowton DL, Haponik EF (1996) Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 335:1864–1869PubMedCrossRef

20.

Anonymous (2004) The ethical conduct of clinical research involving critically ill patients in the United States and Canada. Am J Respir Crit Care Med 170:1375–1384CrossRef

21.

NICE-SUGAR Study Investigators (2005) A multi-centre, open label, randomised controlled trial of two target ranges for glycaemic control in intensive care unit (ICU) patients. Availlable at: http://controlled-trialscom/isrctn/trial/ISRCTN0498275/0/04968275html, accessed 5 February 2006

22.

Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRef

23.

Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Fihlo G, Kariralla RA, Deheinzeline D, Munoz C, Oliveria R (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338:347–354PubMedCrossRef

24.

Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367PubMedCrossRef

25.

Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 166:1510–1514PubMedCrossRef

26.

Bellomo R (2005) Glycemic control in the intensive care unit: why we should wait for NICE-SUGAR. Mayo Clin Proc 80:1546–1548PubMedCrossRef

27.

Parshuram C, Kavanagh B (1983) Meta-analysis of tidal volumes in ARDS. Am J Respir Crit Care Med 167:798

28.

Weijer C (2000) The ethical analysis of risk. J Law Med Ethics 28:344–361PubMed

29.

McRae AD, Weijer C (2002) Lessons from everyday lives: a moral justification for acute care research. Crit Care Med 30:1146–1151PubMedCrossRef

30.

National Bioethics Advisory Commission (2001) Ethical and policy issues in research involving human participants. U.S. Government Printing Office, Rockville

31.

Freeman BD, Danner RL, Banks SM, Natanson C (2001) Safeguarding patients in clinical trials with high mortality rates. Am J Respir Crit Care Med 164:190–192PubMed

32.

Lemaire F, Brun-Buisson C (2000) Are institutional review boards effective in safe-guarding patients in intensive care units? Curr Opin Anaesthesiol 13:195–200PubMedCrossRef

33.

Karlawish JHT (2003) Research involving cognitively impaired adults. N Engl J Med 348:1289–1392CrossRef

34.

National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1977) Research involving children: report and recommendations. U.S. Department of Health, Education and Welfare, Washington

35.

National Bioethics Advisory Commission (1998) Research involving persons with mental disorders that may affect decisionmaking capacity. U.S. Government Printing Office, Rockville

36.

World Medical Association (2000) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. HIV Clin Trials 2001:92–95

37.

Morin K, Rakatansky H, Riddick FA et al. (2002) Managing conflicts of interest in the conduct of clinical trials. JAMA 287:78–84PubMedCrossRef

38.

University of California Office of the President Office of Research (2002) Guidance on surrogate consent for research. Available at: http://www.llnl.gov/HumanSubjects/pdfs/surrogate.pdf; accessed 22 September 2003

39.

Saks ER (1999) Competency to decide on treatment and research. The MacArthur capacity instruments. In: National Bioethics Advisory Commission (ed) Research involving persons with mental disorders that may affect decisionmaking capacity,vol II. Commissioned papers. National Bioethics Advisory Commission, Rockville

40.

Silverman HJ, Luce JM, Schwartz J (2004) Protecting subjects with decisional impairment in research. The need for a multifaceted approach. Am J Respir Crit Care Med 169:10–14PubMedCrossRef

41.

Keyserlingk EW, Kogan GK, Gauthier S (1995) Proposed guidelines for the participation of persons with dementia as research subjects. Perspect Biol Med 38:319–361PubMed

42.

Lidz WW, Appelbaum PS (2002) The therapeutic misconception. Problems and solutions. Med Care 40:V55–V63PubMedCrossRef

43.

Dresser R (2002) The ubiquity and utility of the therapeutic misconception. Soc Philos Policy Foundation 19:271–294CrossRef

44.

Silverman HJ (1996) Ethical considerations of ensuring an informed and autonomous consent in research involving critically ill patients. Am J Respir Crit Care Med 154:582–586PubMed

45.

International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (1997) Consolidated guideline on good clinical practice in the conduct of clinical trials on medicinal products for human use. Int Dig Health Legis 48:231–234

46.

Silverman HJ, Hull SC, Sugarman J (2001) Variability among institutional review boards' decisions within the context of a multicenter trial. Crit Care Med 29:235–241PubMedCrossRef

47.

Advisory Committee on Human Radiation Experiments (1995) Final report. U.S. Government Printing Office, Washington

48.

Silverman HJ, Luce JM, Lanken PN, Morris AH, Harabin AL, Oldmixon CF, Thompson BT, Bernard GR, for the NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network (2005) Recommendations for informed consent forms for critical care clinical trials. Crit Care Med 33:867–882PubMedCrossRef

49.

Estey A, Wilkin G, Dossetor J (1994) Are research subjects able to retain the information they are given during the consent process. Health Law Rev 3:37–41

50.

Williams FF, French JK, White HD, for the HERO-2 consent substudy investigators (2003) Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study. Lancet 361:918–922PubMedCrossRef

51.

Schaeffer MH, Krantz DS, Wichman A, Masur H, Reed E, Vinicky JK (1996) The impact of disease severity on the informed consent process in clinical research. Am J Med 100:261–268PubMedCrossRef

52.

Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W (1987) False hopes and best data: consent to research and the therapeutic misconception. Hastings Cent Rep 17:20–24PubMed

53.

Miller FG, Rosenstein DL (2003) The therapeutic orientation to clinical trials. N Engl J Med 348:1383–1386PubMedCrossRef

54.

Lemaire F (2004) Patient care versus research: does clinical research provide individual benefit to patients enrolled in trials. Curr Opin Crit Care 10:565–569PubMedCrossRef

55.

Appelbaum PS (2002) Clarifying the ethics of clinical research: a path toward avoiding the therapeutic misconception. Am J Bioethics 2:22–23CrossRef

56.

Clemens JD, Frederik FP, van Loon L, Rao M, Sack DA, Ahmed F, Chakraborty J, Khan MR, Yunus M, Harris JR, Svennerholm AM et al. (1992) Nonparticipation as a determinant of adverse health outcomes in a field trial of oral cholera vaccines. Am J Epidemiol 135:865–874PubMed

57.

Peppercorn JM, Weeks JC, Cook EF, Joffe S (2004) Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 363:263–270PubMedCrossRef

58.

Hawkins JS, Emanuel EJ (2005) Clarifying confusions about coercion. Hastings Cent Rep 35:16–19PubMed

59.

Anonymous (2005) Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing of importation of such products. Official J Eur Union L91:13–19

60.

Sulmasy DP, Terry PB, Weisman CS, Miller DJ, Stallings RY, Vettese MA, Haller KB (1998) The accuracy of substituted judgments in patients with terminal diagnoses. Ann Intern Med 128:621–629PubMed

61.

Coppolino M, Ackerson L (2001) Do surrogate decision makers provide accurate consent for intensive care research? Chest 119:603–612PubMedCrossRef

62.

Jones C, Skirrow P, Griffiths R, Humphris G, Ingleby S, Eddleston J, Waldmann C, Gager M (2004) Post-traumatic stress disorder-related symptoms in relatives of patients following intensive care. Intensive Care Med 30:456–460PubMedCrossRef

63.

Pochard F, Azoulay E, Chevret S, Lemaire F, Hubert P, Canoui P, Grassin M, Zittoun R, LeGall JR, Dhainaut JF, Schlemmer B, French FAMIRFA Group (2001) Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med 29:1893–1897PubMedCrossRef

64.

United States Department of Health and Human Services (1996) Protection of human subjects: informed consent and waiver of informed consent requirements in certain emergency research. Final rules, 61. Fed Register 51500–51533

65.

Nichol G, Huszti E, Rokosh J, Dumbrell A, McGowan J, Becker L (2004) Impact of informed consent requirements on cardiac arrest research in the United States: exception from consent or from research? Resuscitation 62:3–23PubMedCrossRef

66.

Hiller KM, Haukoos JS, Heard K, Tashkin JS, Paradis NA (2005) Impact of the final rule on the rate of clinical cardiac arrest research in the United States. Acad Emerg Med 12:1091–1098PubMedCrossRef

67.

Lemaire F (2002) European Society of Intensive Care Medicine statement. Intensive Care Med 28:1218–1219PubMedCrossRef

68.

Lemaire F (2005) Waiving consent for emergency research. Eur J Clin Invest 35:287–289PubMedCrossRef

69.

Morse MA, Califf RM, Sugarman J (2001) Monitoring and ensuring safety during clinical research. JAMA 285:1201–1205PubMedCrossRef

Title: Ethics and research in critical care
Authors: Henry J. Silverman
Francois Lemaire
Publication date: 01-11-2006
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 11/2006
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-006-0305-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ethics and research in critical care

Abstract

Background

Discussion

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Discussion

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2006

Role of routine blood cultures in detecting unapparent infections during continuous renal replacement therapy

Difference in reported pre-morbid health-related quality of life between ARDS survivors and their substitute decision makers

Respiratory failure in infants due to spinal muscular atrophy with respiratory distress type 1

Epidemiology and Peculiarities of Pediatric Multiple Organ Dysfunction Syndrome in New Delhi, India

Abdominal compartment syndrome: it's time to pay attention!

Evaluation of the Binax NOW Streptococcus pneumoniae urinary antigen assay in intensive care patients hospitalized for pneumonia